Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedAug 10, 2025
DataAggregated Company Financials
Companies220
  • 7D2.9%
  • 3M13.1%
  • 1Y-7.1%
  • YTD7.7%

The Healthcare industry is up 2.9% in the last week, with Caliway Biopharmaceuticals up 8.7%. In the past year, the industry is down 7.1%. Looking forward, earnings are forecast to grow by 45% annually.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 10 Aug 2025NT$1.7tNT$262.5bNT$13.6b21.5x121.7x6.3x
Tue, 08 Jul 2025NT$1.6tNT$261.0bNT$16.4b20.4x97.4x6.1x
Thu, 05 Jun 2025NT$1.5tNT$260.9bNT$16.3b19.5x94.4x5.9x
Sat, 03 May 2025NT$1.4tNT$255.2bNT$12.4b20x116.6x5.7x
Mon, 31 Mar 2025NT$1.6tNT$254.0bNT$11.6b21.4x135.3x6.2x
Wed, 26 Feb 2025NT$1.7tNT$246.5bNT$8.4b23.8x197.6x6.8x
Fri, 24 Jan 2025NT$1.5tNT$246.2bNT$8.7b22.2x175.5x6.2x
Sun, 22 Dec 2024NT$1.4tNT$245.0bNT$8.6b21.7x167.1x5.9x
Tue, 19 Nov 2024NT$1.5tNT$244.5bNT$8.0b22.6x183.4x6x
Thu, 17 Oct 2024NT$1.5tNT$236.4bNT$6.8b24.7x225x6.4x
Sat, 14 Sep 2024NT$1.6tNT$236.4bNT$6.8b24.9x232.1x6.6x
Mon, 12 Aug 2024NT$1.6tNT$230.0bNT$3.9b26.4x399.5x6.8x
Wed, 10 Jul 2024NT$1.7tNT$228.8bNT$3.6b28.7x461x7.2x
Fri, 07 Jun 2024NT$1.5tNT$228.6bNT$3.9b27.3x389.3x6.7x
Sun, 05 May 2024NT$1.4tNT$229.4bNT$4.5b25.5x321.9x6.3x
Tue, 02 Apr 2024NT$1.5tNT$228.8bNT$6.4b26.3x231.2x6.5x
Thu, 29 Feb 2024NT$1.5tNT$226.6bNT$6.7b25.8x219.3x6.5x
Sat, 27 Jan 2024NT$1.4tNT$225.0bNT$5.9b24.8x233x6.2x
Mon, 25 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.5x239x6.2x
Wed, 22 Nov 2023NT$1.4tNT$224.7bNT$6.5b24.9x213.3x6.2x
Fri, 20 Oct 2023NT$1.3tNT$225.3bNT$8.3b24.4x160x5.9x
Sun, 17 Sep 2023NT$1.4tNT$225.2bNT$8.2b26.1x170.6x6.2x
Tue, 15 Aug 2023NT$1.3tNT$221.9bNT$7.0b24.6x187.8x6x
Thu, 13 Jul 2023NT$1.4tNT$226.5bNT$11.5b25.2x121.3x6.2x
Sat, 10 Jun 2023NT$1.4tNT$225.0bNT$11.1b24.9x130x6.4x
Mon, 08 May 2023NT$1.5tNT$220.1bNT$12.0b25.2x123.6x6.8x
Wed, 05 Apr 2023NT$1.4tNT$221.6bNT$13.1b22.1x108.8x6.4x
Fri, 03 Mar 2023NT$1.5tNT$215.2bNT$14.4b21.5x100.9x6.7x
Sun, 29 Jan 2023NT$1.3tNT$214.5bNT$13.8b20.1x94.3x6.1x
Tue, 27 Dec 2022NT$1.3tNT$214.5bNT$13.8b20.9x95.6x6.2x
Thu, 24 Nov 2022NT$1.3tNT$214.4bNT$14.1b17.5x92.5x6.1x
Sat, 22 Oct 2022NT$1.1tNT$207.4bNT$10.8b18.5x103.6x5.4x
Mon, 19 Sep 2022NT$1.4tNT$207.4bNT$10.8b21.4x131.3x6.8x
Wed, 17 Aug 2022NT$1.3tNT$207.7bNT$12.5b20.4x101.9x6.1x
Price to Earnings Ratio

101.9x


Total Market Cap: NT$1.3tTotal Earnings: NT$12.5bTotal Revenue: NT$207.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 179.4x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 122x which is lower than its 3-year average PE of 179x.
  • The industry is trading close to its 3-year average PS ratio of 6.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 2.9% per year over the last three years.
  • Revenues for these companies have grown 8.1% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market2.50%
Healthcare2.92%
Pharma4.77%
Biotech3.66%
Healthcare Services1.79%
Healthtech0.54%
Life Sciences-0.69%
Medical Equipment-1.31%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 213x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 71% over the next 5 years.
  • This is better than its past earnings growth rate of 6.0% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 18% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6919 Caliway BiopharmaceuticalsNT$131.508.7%
+NT$16.3b		123.6%PS5040x
6949 Pell Bio-Med TechnologyNT$339.0059.9%
+NT$7.4b		230.7%PS744.3x
6446 PharmaEssentiaNT$510.002.7%
+NT$4.5b		-25.9%PE43.6x
6472 Bora PharmaceuticalsNT$717.004.0%
+NT$3.4b		9.9%PE14.9x
6945 AP BiosciencesNT$137.0031.1%
+NT$2.8b		160.0%PB7.2x

Latest News

6499
NT$102.50
Medeon Biodesign
7D
-13.1%
1Y
138.9%
6535
NT$142.00
Lumosa Therapeutics
7D
11.8%
1Y
-33.3%
6782
NT$197.50
Visco Vision
7D
17.2%
1Y
-5.3%
1786
NT$95.00
SciVision Biotech
7D
-19.8%
1Y
-14.4%
4147
NT$78.80
TaiMed Biologics
7D
-4.3%
1Y
0.5%
1720
NT$55.00
Standard Chemical & Pharmaceutical
7D
-4.2%
1Y
-16.8%
6785
NT$180.00
Alar Pharmaceuticals
7D
21.6%
1Y
-5.5%
7799
NT$847.00
Heron Neutron Medical
7D
-4.0%
1Y
n/a
6919
NT$131.50
Caliway Biopharmaceuticals
7D
8.7%
1Y
123.6%
4728
NT$409.00
Sunmax Biotechnology
7D
-2.6%
1Y
45.3%
6472
NT$717.00
Bora Pharmaceuticals
7D
4.0%
1Y
9.9%
author-image

US Facility Modernization Will Secure Future Specialty Success

Strategic shift to high-value CDMO services and facility upgrades has improved margins, driven growth, and positioned the company for market share gains.
6446
NT$510.00
PharmaEssentia
7D
2.7%
1Y
-25.9%
3705
NT$58.80
YungShin Global Holding
7D
-5.3%
1Y
7.3%
6547
NT$40.70
Medigen Vaccine Biologics
7D
-6.0%
1Y
-8.0%
6949
NT$339.00
Pell Bio-Med Technology
7D
59.9%
1Y
230.7%
6945
NT$137.00
AP Biosciences
7D
31.1%
1Y
160.0%